Literature DB >> 8405851

Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog.

J G Geoghegan1, D C Lawson, C A Cheng, E Opara, I L Taylor, T N Pappas.   

Abstract

BACKGROUND: Neuropeptide Y (NPY), a centrally located neurotransmitter, is known to increase appetite in fasted and satiated animals. In addition to evaluating NPY's effect on eating behavior, this study was intended to determine whether intracerebroventricular (ICV) NPY would have an effect on canine gastric and pancreatic secretion.
METHODS: Four dogs were prepared with cerebroventricular guides and gastric and pancreatic fistulas. ICV and intravenous NPY was administered during intragastric titration of a glucose and peptone meal. During this study, gastric and pancreatic secretion was measured, as well as insulin levels and pancreatic polypeptide (PP). An additional set of four dogs were prepared with esophageal fistulas and cerebroventricular guides, and the effect of ICV NPY on sham feeding was studied.
RESULTS: ICV NPY significantly increased sham feeding, meal-stimulated gastric and pancreatic secretion, basal gastric acid, pancreatic bicarbonate, insulin levels, and PP. Vagotomy blocked the effect of ICV NPY on gastric acid secretion in a urethane-anesthetized rat model with acute gastric fistula.
CONCLUSIONS: ICV NPY increased sham feeding, gastric and pancreatic secretion, insulin levels, and PP in the dogs. NPY's effect on gastric secretion was blocked by vagotomy in a rat model. NPY should be considered a candidate mediator of cephalic phase secretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405851     DOI: 10.1016/0016-5085(93)90951-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Regulation of hepatic function by brain neuropeptides.

Authors:  Masashi Yoneda
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

Review 2.  Brain-gut axis of the liver: the role of central neuropeptides.

Authors:  Masashi Yoneda; Mieko Kurosawa; Hajime Watanobe; Tadahito Shimada; Akira Terano
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

3.  Central peptidergic control of gastric acid secretion.

Authors:  J G Geoghegan; T N Pappas
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

4.  Gastric distension-induced pyloric relaxation: central nervous system regulation and effects of acute hyperglycaemia in the rat.

Authors:  T Ishiguchi; M Nakajima; H Sone; H Tada; A K Kumagai; T Takahashi
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

5.  Ghrelin action in the brain controls adipocyte metabolism.

Authors:  Claudia Theander-Carrillo; Petra Wiedmer; Philippe Cettour-Rose; Ruben Nogueiras; Diego Perez-Tilve; Paul Pfluger; Tamara R Castaneda; Patrick Muzzin; Annette Schürmann; Ildiko Szanto; Matthias H Tschöp; Françoise Rohner-Jeanrenaud
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

6.  Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  J Physiol       Date:  2003-05-02       Impact factor: 5.182

7.  Modulation of inhibitory neurotransmission in brainstem vagal circuits by NPY and PYY is controlled by cAMP levels.

Authors:  K N Browning; R A Travagli
Journal:  Neurogastroenterol Motil       Date:  2009-07-20       Impact factor: 3.598

8.  An Indirect Action Contributes to C-Fos Induction in Paraventricular Hypothalamic Nucleus by Neuropeptide Y.

Authors:  Shengjie Fan; Janani Dakshinamoorthy; Eun Ran Kim; Yong Xu; Cheng Huang; Qingchun Tong
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.